Chrome Extension

WeChat Mini Program

Use on ChatGLM

Log in

Academic Profile User Profile

My Following Paper Collections Browse History

Impact of Lorlatinib on Patient-Reported Outcomes in Patients with Advanced ALK-positive or ROS1-positive Non-Small Cell Lung Cancer

Solange Peters,Alice T. Shaw,Benjamin Besse,Enriqueta Felip,Benjamin J. Solomon,Ross A. Soo,Alessandra Bearz,Shirish M. Gadgeel,Chia-Chi Lin,Steven Kao,Takashi Seto,Elizabeth T. Masters,Antonello Abbattista,Jill S. Clancy,Holger Thurm,Arlene Reisman,Gerson Peltz,D. Ross Camidge

Lung cancer（2020）

Cited 14|Views150

No score

Key words

ALK,Lorlatinib,NSCLC,Patient-reported outcomes,QoL,ROS1

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined